Effects of transdermal estrogen replacement on parathyroid hormone secretion.
The effect of transdermal 17 beta-estradiol replacement on ionized calcium and PTH levels was examined in 15 postmenopausal women. After baseline studies in the fasting state, the effect of a calcium infusion on PTH levels was studied. Estrogen replacement resulted in a fall in fasting resting ionized calcium and a rise in PTH levels. After calcium infusion there was no change in the shape of the relationship between plasma calcium and PTH. The level of nonsuppressible PTH secretion was not altered. Transdermal estrogen did not alter basal vitamin D-binding protein levels, 25-hydroxyvitamin D levels, or calcitriol levels. We conclude that the effect of transdermal estrogen replacement on PTH secretion is completely explained by the lowering of ionized calcium, causing a rise in PTH secretion. Thus, with this route of estrogen replacement, there is no necessity to postulate a direct effect of 17 beta-estradiol on the parathyroid gland.
Prince
R L
RL
Department of Medicine, University of Western Australia, Perth.
Schiff
I
I
Neer
R M
RM
D000279:Administration, Cutaneous; D000328:Adult; D002118:Calcium / Q000008:administration & dosage / Q000097:blood; D004967:Estrogens / Q000008:administration & dosage* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D008593:Menopause / Q000502:physiology*; D008875:Middle Aged; D010280:Parathyroid Glands / Q000187:drug effects / Q000502:physiology; D010281:Parathyroid Hormone / Q000097:blood* / Q000378:metabolism
D004967:Estrogens; D010281:Parathyroid Hormone; D002118:Calcium